Jerome F Strauss

This inventor holds 6 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Virginia Commonwealth University, The Penn State Research Foundation. Active years: 2010-2020.

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 66.7

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

6 out of 420

Virginia Commonwealth University

patents

5 out of 1,339

The Penn State Research Foundation

patents

where one patent can have more than one assignee

Years Active: 2010-2020

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10865448 - Compositions and methods relating to DENND1A variant 2 and polycystic ovary syndrome (2020-12-15),

2. 10723790 - Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of DENN/MADD domain containing 1A variant 2 (DENND1A variant 2) (2020-07-28),

3. 10183991 - Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A variant 2) (2019-01-22),

4. 9957567 - Methods relating to DENND1A Variant 2 and polycystic ovary syndrome (2018-05-01),

5. 9676844 - Pharmaceutical compositions comprising DENND1A variant 2 and methods of use thereof (2017-06-13),

6. 7807366 - Genetic markers for assessing risk of premature birth resulting from preterm premature rupture of membranes (2010-10-05),

Title: Jerome F. Strauss: Innovator in Polycystic Ovary Syndrome Research

Introduction

Jerome F. Strauss is a notable inventor based in Richmond, VA (US), recognized for his contributions to the field of medical research, particularly in relation to polycystic ovary syndrome (PCOS). With a total of 6 patents, Strauss has made significant strides in developing diagnostic methods and therapeutic approaches for this condition.

Latest Patents

Among his latest patents, Strauss has developed compositions and methods relating to DENND1A variant 2 and polycystic ovary syndrome. These innovations include methods for diagnosing PCOS by analyzing samples for DENND1A Variant 2 mRNA or protein. Additionally, he has provided methods for selecting candidates for therapy based on the presence of DENND1A Variant 2 in biological samples. His work also encompasses pharmaceutical compositions and methods for treating DENND1A.V2 related disorders, including humanized and mouse monoclonal antibodies specific for DENND1A.V2.

Career Highlights

Throughout his career, Strauss has been affiliated with prominent institutions such as Virginia Commonwealth University and The Penn State Research Foundation. His research has significantly impacted the understanding and treatment of polycystic ovary syndrome, making him a key figure in this area of study.

Collaborations

Jerome F. Strauss has collaborated with notable colleagues, including Janette M. McAllister and Neil D. Christensen. These partnerships have further enhanced the scope and impact of his research efforts.

Conclusion

Jerome F. Strauss stands out as an influential inventor in the realm of medical research, particularly in the diagnosis and treatment of polycystic ovary syndrome. His innovative patents and collaborations continue to contribute to advancements in healthcare.